Long Term Use of Somavert (Pegvisomant) For A Regulatory Post Marketing Commitment Plan

CompletedOBSERVATIONAL
Enrollment

251

Participants

Timeline

Start Date

August 7, 2007

Primary Completion Date

November 9, 2016

Study Completion Date

November 9, 2016

Conditions
Acromegaly
Interventions
DRUG

Somavert (Pegvisomant)

"Somavert (Pegvisomant) 10, 15 or 20mg powder and solvent for solution for injection.~Dosage, Frequency : According to Japanese LPD.~Duration : According to the protocol of A6291023, the duration of the investigation for findings regarding safety and efficacy of a patient is from the first drug administration to the 5 years after the first administration."

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00658879 - Long Term Use of Somavert (Pegvisomant) For A Regulatory Post Marketing Commitment Plan | Biotech Hunter | Biotech Hunter